Literature DB >> 7381326

Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.

K H Weisgraber, R W Mahley.   

Abstract

A reproducible and quantitative subfractionation of human high density lipoproteins (HDL) by heparin-Sepharose affinity chromatography has been developed. Two elution methods (A and B) were used to subfractionate HDL(2) (d 1.063-1.125 g/ml) or total HDL (d 1.063-1.21 g/ml). Method A separated HDL(2) into three subclasses, each with distinct chemical properties and in vitro metabolic characteristics. The first subclass, referred to as HDL(2)-without E, passed through the affinity column unretarded and represented approximately 85% of the HDL(2) lipoprotein protein. HDL(2)-without E contained the A-I, A-II, and C apoproteins which characterize typical HDL. The second subclass eluted from the column (7-10% of the protein) contained, in addition to the A-I and A-II apoproteins, the E and (E-A-II) apoproteins, and was designated as HDL(2)-with E. The B apoprotein was the major protein component of the third subclass eluted from the column (beta lipoproteins). The beta subclass accounted for approximately 3-8% of the HDL(2) protein and was similar to Lp(a) in composition and size. Method B further subdivided the beta subclass into two fractions (beta(1) and beta(2)) with slightly different electrophoretic mobilities. The various heparin-Sepharose subclasses were further characterized by their ability to compete with (125)I-labeled low density lipoproteins (LDL) for binding to cell surface receptor sites of fibroblasts. By virtue of the presence of the E apoprotein, HDL(2)-with E competed effectively with (125)I-labeled LDL for binding to the cell surface receptors, whereas HDL(2)-without E were ineffective in competing with LDL. The beta subclass possessed binding capability similar to that of LDL. Subfractionation of HDL by heparin-Sepharose affinity column chromatography provides an attractive alternative to methods based solely on ultracentrifugation, in that it subfractionates HDL into subclasses with differing apoprotein contents that impart distinct metabolic characteristics to each class.-Weisgraber, K. H., and R. W. Mahley. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381326

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  Characterization of the binding of human low-density lipoprotein to primary monolayer cultures of rat hepatocytes.

Authors:  A M Salter; J Saxton; D N Brindley
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

2.  The isolation and characterization of high-density-lipoprotein subfractions containing apolipoprotein E from human plasma.

Authors:  H M Wilson; B A Griffin; C Watt; E R Skinner
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.

Authors:  F Plane; K R Bruckdorfer; P Kerr; A Steuer; M Jacobs
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Plasma lipoproteins in dairy cows with naturally occurring severe fatty liver: evidence of alteration in the distribution of apo A-I-containing lipoproteins.

Authors:  A Mazur; E Marcos; Y Rayssiguier
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

5.  Physicochemical transfer of [3H]cholesterol from plasma lipoproteins to cultured human fibroblasts.

Authors:  B B Lundberg; L A Suominen
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

6.  Detection of the low-density-lipoprotein receptor with biotin-low-density lipoprotein. A rapid new method for ligand blotting.

Authors:  D P Wade; B L Knight; A K Soutar
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

7.  Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.

Authors:  J P McVicar; S T Kunitake; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia.

Authors:  A Corsini; P Roma; D Sommariva; R Fumagalli; A L Catapano
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.

Authors:  Chonglun Xie; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

10.  Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

Authors:  C B Blum; R J Deckelbaum; L D Witte; A R Tall; J Cornicelli
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.